FDA Adverse Event Malfunction Summary report: N

MAMMOMARK BIOPSY IDENTIFIER

MDR report key: 3922457 · Received June 3, 2014

Report

Report Number
3008492462-2014-00019
Event Type
Malfunction
Date Received
June 3, 2014
Date of Event
May 5, 2014
Report Date
June 3, 2014
Manufacturer
DEVICOR MEDICAL PRODUCTS INC.
Product Code
NEU
PMA / PMN Number
K082278
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). INVESTIGATION SUMMARY: THE DEVICE WAS NOT RETURNED FOR ANALYSIS, WHICH PREVENTED A FULL INVESTIGATION AND ANALYSIS OF THE ROOT CAUSE. HOWEVER, BASED ON OUR KNOWLEDGE OF THE DEVICE DESIGN AND ITS PRESCRIBED USE, THE MOST LIKELY SCENARIO IS THAT THE USER REMOVED THE MARKER APPLICATOR SEPARATELY FROM THE BIOPSY PROBE. TIP SHEAR HAS BEEN IDENTIFIED AS A POTENTIAL RISK WHENEVER THE APPLICATOR SHAFT IS REMOVED THROUGH THE BIOPSY PROBE. OUR MAMMOTOME VACUUM ASSISTED BIOPSY PROBES CONTAIN EXTREMELY SHARP EDGES ALONG THE APERTURE OPENING TO EFFECTIVELY EXCISE TISSUE. REMOVING THE APPLICATOR SHAFT CREATES THE PASSIBILITY OF THE APPLICATOR CATCHING ON ONE OF THESE EDGES AND SHEARING. AS A MITIGATION STEP TO ADDRESS THIS RISK, WE PROVIDE CONTRAINDICATION LANGUAGE AND INSTRUCTION WITHIN THE INSTRUCTIONS FOR USE: WARNING: FAILURE TO ALIGN THE MAMMOMARK APPLICATOR AS SPECIFIED MAY RESULT IN IMPROPER DEPLOYMENT OF THE COLLAGEN PLUG AND POSSIBLE TIP SHEAR. WARNING #10: REMOVE THE MAMMOMARK APPLICATOR AND THE MAMMOTOME BIOPSY PROBE TOGETHER AS A SINGLE UNIT FROM THE SITE AND OBTAIN IMAGES TO CONFIRM MARKER PLACEMENT.

Description of Event or Problem · 1

THE SALES REP REPORTED THAT ACCOUNT HAD ISSUE DEPLOYING TWO MARKERS DURING REVOLVE CASE. STATED FIRST ONE DID NOT DEPLOY AT ALL AND SECOND ONE WAS SHEARED OFF.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
323180 MAMMOMARK BIOPSY IDENTIFIER TISSUE MARKER NEU DEVICOR MEDICAL PRODUCTS INC. MMK0802 F1138516D1

Patients

Seq Age Sex Outcome Treatment
1 UNK